The UKs pilot scheme offering free chlamydia testing in pharmacies is to be applauded but a number of issues need to be resolved if it is to be a success, concludes an editorial in this weeks issue of The Lancet.
Chlamydia is the most common bacterial sexually transmitted disease. Recent reports suggest that more than 10 percent of Japanese teenagers are infected with chlamydia, that the incidence of chlamydia infection in UK men rose by around 15 percent between 2001 and 2002, and that the prevalence of chlamydia in black American women is over 13 percent. The UK Health Protection Agency has found that in 45 to 64 year old women, rates of chlamydial infection rose by 177 percent between 1995 and 2003.
Melanie Johnson, UK public health minister, announced last week a two-year pilot scheme to offer free Chlamydia trachomatis testing in pharmacies. Although limited to London and Cornwall initially, if successful the scheme would be extended to involve the whole of the UK. However, as independent health-care providers submit bids to provide the service, the broader issues involved in screening for chlamydia, and STIs in general, must be addressed, states the editorial.
The Lancet comments: Although pharmacists are experts in providing medicines and guidance about their use, will adequate training and staffing be available to explain the testing process and the meaning of the results, be they positive or negative? How will the testing process be linked to the provision of follow up for those testing positive whether or not they receive treatment? Who will provide the sexual contact tracing facilities for people with newly diagnosed sexual infections? Who will provide safe sex advice, and who will address the issues of testing for other STIs in an at risk population? These difficult and sensitive issues require careful consideration if the governments innovation is to be a success.
Source: The Lancet
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
Broadening the Path: Diverse Educational Routes Into Infection Prevention Careers
July 4th 2025Once dominated by nurses, infection prevention now welcomes professionals from public health, lab science, and respiratory therapy—each bringing unique expertise that strengthens patient safety and IPC programs.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.